Search Results - "Brechelmacher, S"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer by Gampenrieder, S P, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R

    Published in The pharmacogenomics journal (01-07-2017)
    “…Biomarkers for bevacizumab efficacy in metastatic breast cancer (MBC) are of urgent need. The genetic variability of genes involved in angiogenesis could…”
    Get full text
    Journal Article
  2. 2

    Abstract P1-08-32: Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer by Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Muß, C, Pircher, M, Ressler, S, Kronberger, C, Mlineritsch, B, Greil, R

    Published in Cancer research (Chicago, Ill.) (15-12-2013)
    “…Background: Biomarkers predicting response or toxicity of bevacizumab containing therapy in breast cancer are of urgent need. The genetic variability of VEGF,…”
    Get full text
    Journal Article